Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Vectus Biosystems Limited (ASX: VBS) - Share Price and Research
- Current share price for VBS : $0.250
Vectus Biosystems Limited (VBS), an ASX-listed company, is developing a treatment for fibrosis and high blood pressure, which includes the treatment for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. The Company has also developed technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
VBS General Information +
| ASX Code | VBS |
| Website | http://www.vectusbiosystems.com.au |
| Industry/Sector | Biotechnology |
| Market Cap ($M) | 13 |
| VBS Share Price | $0.250 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.250 |
| VBS Share Price Movement | - ( No change ) |
Prices as at 16:40, 16 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
VBS Related Research
Vectus Biosystems Limited (VBS) Upcoming Dividends & Yields
There are no dividends for Vectus Biosystems Limited (VBS). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Vectus Biosystems Limited (VBS) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Half Year Report & Appendix 4D | 23 Feb 2024 4:14PM | $0.295 | $0.250 | $0.280 | fallen by 15.25% |
| Quarterly Activities & Appendix 4C Cash Flow Reports | 31 Jan 2024 3:54PM | $0.300 | $0.250 | $0.280 | fallen by 16.67% |
| Change in substantial holding | 6 Dec 2023 4:48PM | $0.315 | $0.250 | $0.280 | fallen by 20.63% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Vectus Biosystems Limited (VBS) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
VBS Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | -$3.45 | -$7.20 | -39.90% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$3.99 | -$12.00 | -21.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2021A | -$4.28 | -$15.20 | 19.40% | 0.00 | 0.00 | 0.00% | 0.0% |
VBS Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| CSL (CSL) | $134,610M | -0.0712 | 0.1072 | 0.1864 | 40.7678 | 36.8209 | 31.0362 | 1.28% | 1.20% | 1.35% |
| Clinuvel Pharmaceuticals (CUV) | $762M | 0.4665 | 0.2049 | 0.1566 | 25.7191 | 21.3453 | 18.4556 | 0.33% | 0.46% | 0.53% |
| Mesoblast (MSB) | $947M | -0.1037 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Telix Pharmaceuticals (TLX) | $4,266M | -1.3767 | 0.0000 | 0.0000 | 102.2979 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Vectus Biosystems (VBS) | $13M | -0.3993 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
VBS Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 3.78 | 0.00 |
| Market | 0.52 | 15.00 | 1.11 | 1.02 |
| Sector | 1.27 | 21.40 | 1.95 | 0.98 |
VBS Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Karen Annette Duggan | Chief Executive Officer, Executive Director | 4 Sep 2006 |
| Mr Maurie Stang | Non-Executive Deputy Chairman, Non-Executive Director | 12 Dec 2005 |
| Dr Susan Margaret Pond | Non-Executive Director | 4 May 2016 |
| Dr Ronald Cecil Shnier | Non-Executive Director, Non-Executive Chairman | 2 Sep 2015 |
Vectus Biosystems Limited (VBS) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 28 Dec 2022 | STANG, Maurie | Issued | Indirect Shares | 12,500 | $0.800 | $10,000.000 |
| 28 Dec 2022 | SHNIER, Ronald | Issued | Indirect Shares | 37,500 | $0.800 | $30,000.000 |
| 28 Dec 2022 | POND, Susan | Issued | Indirect Shares | 18,750 | $0.800 | $15,000.000 |
See all changes in directors' interest & trades for Vectus Biosystems Limited (VBS) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
VBS Management
| Name | Position |
|---|---|
| Robert John Waring | Company Secretary |
VBS Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Vectus Biosystems Limited (VBS). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 5,178,668 (9.73%) | Kefford Holdings Pty Ltd |
| 4,858,952 (9.14%) | Maurie Stang |
| 4,457,782 (8.38%) | Regal Funds Management Pty Ltd |
| 3,278,500 (6.16%) | Karen Duggan |
| 2,560,500 (4.81%) | Bernard stang |
VBS Calendar of Events
| Date | Event |
|---|---|
| 21 February 2025 | Report (Interim) |
| 28 August 2024 | Report (Annual) |
| 28 August 2024 | Report (Prelim) |
FAQs about Vectus Biosystems Limited (VBS)
What is the current share price of Vectus Biosystems Limited (VBS)?
Vectus Biosystems Limited's (VBS) current share price is $0.25. This constitutes a price movement of 10.71% when compared to the share price 7 days ago and is -57.98% below VBS's 12-month high of $0.60 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Vectus Biosystems Limited (VBS)?
Relative to the previous close share price of $0.25, Vectus Biosystems Limited's (VBS) current share price of $0.25 constitutes a movement of or 0%. Vectus Biosystems Limited's (VBS) share price movement is -10.71% when compared to 7 days ago and is -57.98% below VBS's 52-week high of $0.60.
What is the 52-week high share price for Vectus Biosystems Limited (VBS)?
Vectus Biosystems Limited's (VBS) 52-week high is $0.60 which was reached on 18 Apr 2023. Relative to this, VBS's current share price of $0.25 constitutes a -$0.35 or -57.98% drop since that high of $0.60 per VBS share.
What is the 52-week low share price for Vectus Biosystems Limited (VBS)?
Vectus Biosystems Limited's (VBS) 52-week low is $0.20 which was reached on 1 Mar 2024. Relative to this, VBS's current share price of $0.25 constitutes a $0.05 or 25% gain since that low of $0.20 per VBS share.
What is the daily average trading volume for Vectus Biosystems Limited (VBS)?
Over the last 12 months, Vectus Biosystems Limited (VBS) has a daily average trading volume of 18,796 VBS shares per day.
What is the dividend yield for Vectus Biosystems Limited (VBS)?
Vectus Biosystems Limited (VBS) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for VBS is a ratio that tells you the percentage of Vectus Biosystems Limited's (VBS) share price that it pays out in dividends each year.
When does Vectus Biosystems Limited (VBS) release its next Annual Report?
Vectus Biosystems Limited (VBS) will release its next Annual Report on 28 August 2024. Vectus Biosystems Limited's (VBS) last annual report was released on 30 Aug 2023. Click here to view Vectus Biosystems Limited's (VBS) last annual report.
In which sector is Vectus Biosystems Limited (VBS) classified?
Vectus Biosystems Limited (VBS) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for Vectus Biosystems Limited (VBS)?
The price-to-earnings (P/E) ratio for Vectus Biosystems Limited (VBS) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Vectus Biosystems Limited's (VBS) share price to its earnings per VBS share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
